(Q33788925)

29 July 2017

1 reference

title

Late toxicity following curative treatment of testicular cancer (English)

1 reference

29 July 2017

1 reference

Kollmannsberger C

1

1 reference

29 July 2017

Kuzcyk M

2

1 reference

29 July 2017

Mayer F

3

1 reference

29 July 2017

Hartmann JT

4

1 reference

29 July 2017

Kanz L

5

1 reference

29 July 2017

Bokemeyer C

6

1 reference

29 July 2017

publication date

1 December 1999

1 reference

Journal of Surgical Oncology

29 July 2017

published in

1 reference

29 July 2017

volume

17

1 reference

29 July 2017

issue

4

1 reference

29 July 2017

page(s)

275-281

1 reference

Effects of cisplatin on different measures of glomerular function in the human kidney with special emphasis on high-dose.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199912%2917%3A4%3C275%3A%3AAID-SSU9%3E3.0.CO%3B2-U

The late effects of cis-platinum on renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199912%2917%3A4%3C275%3A%3AAID-SSU9%3E3.0.CO%3B2-U

Acute and long-term nephrotoxicity of cis-platinum in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199912%2917%3A4%3C275%3A%3AAID-SSU9%3E3.0.CO%3B2-U

Long-term sequelae of treatment for testicular germ cell tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199912%2917%3A4%3C275%3A%3AAID-SSU9%3E3.0.CO%3B2-U

Long-term effects of chemotherapy in patients with testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199912%2917%3A4%3C275%3A%3AAID-SSU9%3E3.0.CO%3B2-U

Creatinine clearance as a predictor of ultrafilterable platinum disposition in cancer patients treated with cisplatin: relationship between peak ultrafilterable platinum plasma levels and nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199912%2917%3A4%3C275%3A%3AAID-SSU9%3E3.0.CO%3B2-U

High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199912%2917%3A4%3C275%3A%3AAID-SSU9%3E3.0.CO%3B2-U

A phase I study of high-dose ifosfamide and escalating doses of carboplatin with autologous bone marrow support

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199912%2917%3A4%3C275%3A%3AAID-SSU9%3E3.0.CO%3B2-U

Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199912%2917%3A4%3C275%3A%3AAID-SSU9%3E3.0.CO%3B2-U

Long-term neurotoxicity in patients treated with cisplatin, vinblastine, and bleomycin for metastatic germ cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199912%2917%3A4%3C275%3A%3AAID-SSU9%3E3.0.CO%3B2-U

Severe, disabling neurologic toxicity following cisplatin retreatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199912%2917%3A4%3C275%3A%3AAID-SSU9%3E3.0.CO%3B2-U

Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199912%2917%3A4%3C275%3A%3AAID-SSU9%3E3.0.CO%3B2-U

Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199912%2917%3A4%3C275%3A%3AAID-SSU9%3E3.0.CO%3B2-U

Cis-diaminedichloro platinum ototoxicity. An experimental study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199912%2917%3A4%3C275%3A%3AAID-SSU9%3E3.0.CO%3B2-U

Dose-dependent impairment of testicular function in patients treated with cisplatin-based chemotherapy for germ cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199912%2917%3A4%3C275%3A%3AAID-SSU9%3E3.0.CO%3B2-U

Fertility after chemotherapy for testicular germ cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199912%2917%3A4%3C275%3A%3AAID-SSU9%3E3.0.CO%3B2-U

Incidence of second primary cancer following testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199912%2917%3A4%3C275%3A%3AAID-SSU9%3E3.0.CO%3B2-U

Second cancer risk following testicular cancer: a follow-up study of 1,909 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199912%2917%3A4%3C275%3A%3AAID-SSU9%3E3.0.CO%3B2-U

Treatment of testicular cancer and the development of secondary malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199912%2917%3A4%3C275%3A%3AAID-SSU9%3E3.0.CO%3B2-U

Osteosarcomas and adult soft tissue sarcomas: Is there a place for high LET radiation therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199912%2917%3A4%3C275%3A%3AAID-SSU9%3E3.0.CO%3B2-U

Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high-dose chemotherapy with stem cell support in patients with potentially curable malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199912%2917%3A4%3C275%3A%3AAID-SSU9%3E3.0.CO%3B2-U

Epipodophyllotoxin-related leukemia. Identification of a new subset of secondary leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199912%2917%3A4%3C275%3A%3AAID-SSU9%3E3.0.CO%3B2-U

Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199912%2917%3A4%3C275%3A%3AAID-SSU9%3E3.0.CO%3B2-U

Secondary leukemia associated with a conventional dose of etoposide: review of serial germ cell tumor protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199912%2917%3A4%3C275%3A%3AAID-SSU9%3E3.0.CO%3B2-U

Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199912%2917%3A4%3C275%3A%3AAID-SSU9%3E3.0.CO%3B2-U

Association of CYP3A4 genotype with treatment-related leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199912%2917%3A4%3C275%3A%3AAID-SSU9%3E3.0.CO%3B2-U

Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199912%2917%3A4%3C275%3A%3AAID-SSU9%3E3.0.CO%3B2-U

Second primary malignancy after Hodgkin's disease, ovarian cancer and cancer of the testis: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199912%2917%3A4%3C275%3A%3AAID-SSU9%3E3.0.CO%3B2-U

Second non-germ cell malignancies after radiotherapy of testicular cancer with or without chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199912%2917%3A4%3C275%3A%3AAID-SSU9%3E3.0.CO%3B2-U

Risk of Second Malignant Neoplasms Among Long-term Survivors of Testicular Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2388%28199912%2917%3A4%3C275%3A%3AAID-SSU9%3E3.0.CO%3B2-U

10.1002/(SICI)1098-2388(199912)17:4<275::AID-SSU9>3.0.CO;2-U

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference